Edward Andrle is Director of NEUROONE MEDICAL TECHNOLOGIES Corp. Currently has a direct ownership of 92,003 shares of NMTC, which is worth approximately $103,043. The most recent transaction as insider was on Feb 14, 2025, when has been sold 27,778 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 92K
43.25% 3M change
43.25% 12M change
Total Value Held $103,043

Edward Andrle Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 14 2025
BUY
Grant, award, or other acquisition
-
27,778 Added 23.19%
92,003 Common Stock
Mar 16 2023
BUY
Grant, award, or other acquisition
-
20,576 Added 24.26%
64,225 Common Stock
May 31 2022
BUY
Grant, award, or other acquisition
-
29,240 Added 40.12%
43,649 Common Stock
Jun 02 2021
BUY
Grant, award, or other acquisition
-
4,592 Added 24.17%
14,404 Common Stock
EA

Edward Andrle

Director
Eden Prairie, MN

Track Institutional and Insider Activities on NMTC

Follow NEUROONE MEDICAL TECHNOLOGIES Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NMTC shares.

Notify only if

Insider Trading

Get notified when an Neuroone Medical Technologies Corp insider buys or sells NMTC shares.

Notify only if

News

Receive news related to NEUROONE MEDICAL TECHNOLOGIES Corp

Track Activities on NMTC